Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHH-1V81 Booster Vaccine for COVID-19
NCT06181292Phase 3Completed
- Sponsor
- HIPRA
- Start
- Nov 2023
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of PHH-1V81 in Coronavirus Disease 2019 (COVID-19), sponsored by HIPRA. Started Nov 2023; status: completed.
02
Drugs
PHH-1V81
03
Conditions
Coronavirus Disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06181292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06181292.